Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

US Patent 8283342 · Granted Oct 9, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combinations comprising MABA compounds and corticosteroids2019
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2019
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist a2018
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2017
Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic an2017
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having b2017
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having b2017
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2017
Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist 2016
Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-2016
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2016
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antag2016